18 Recruiting Hepatocellular Carcinoma Phase 1 Clinical Trials
Active phase 1 studies for hepatocellular carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Hepatocellular Carcinoma studiesPhase 1 Studies for Hepatocellular Carcinoma
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
📍 University of California, San Diego — San Diego, California
View Study & Checklist ➔Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔SBRT + Atezolizumab + Bevacizumab in Resectable HCC
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
📍 Hoag Hospital Newport Beach — Newport Beach, California
View Study & Checklist ➔Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
📍 Virginia Commonwealth University — Richmond, Virginia
View Study & Checklist ➔Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
📍 Research Site — La Jolla, California
View Study & Checklist ➔GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔SBRT With Atezo/Bev for HCC
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
📍 The Kirklin Clinic of University of Alabama Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔A Study of ZW251 in Participants With Advanced Solid Tumors
📍 UCSF Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
📍 Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA — Philadelphia, Pennsylvania
View Study & Checklist ➔Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
📍 City of Hope National Medical Center /ID# 258645 — Duarte, California
View Study & Checklist ➔A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
📍 Dothan — Dothan, Alabama
View Study & Checklist ➔